Podium Session: Non-Prostate GU Cancers
01/01/70 from 21:45 to 22:15
  • POD-4 Patient trajectories of a real-world cohort initiating neoadjuvant chemotherapy for localized muscle-invasive bladder cancer: a population-based study analyzed by a multi-state modelling framework
    Dr. Marian S. Wettstein, Canada
  • MP-16 Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ macrophages, B cells and PD-L1 immune checkpoint
    Dr. Kashif Visram, Canada
  • MP-17 Association between chronic urinary catheterization and bladder cancer incidence and mortality: A population-based study
    Dr. Amanda E Hird, Canada
  • MP-18 Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancer
    Mr. Steven SL Lu, Canada
  • MP-19 Role of the upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma
    Dr. Alice Dragomir, Canada
  • MP-20 Minimizing follow-up intensity of active surveillance for clinical stage 1 non-seminoma germ cell tumours (CS1 NSGCT): A 40-year experience at Princess Margaret Cancer Centre
    Mr. Peter Gariscsak, Canada

© 2022 CUA 74th Annual Meeting